JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Internal Medicine Section DOI : 10.7860/JCDR/2016/19500.8384
Year : 2016 | Month : Aug | Volume : 10 | Issue : 08 Full Version Page : OC35 - OC38

Markers of Oxidative Stress and Clinical Outcome in Critically ill Septic Patients: A Preliminary Study from North India

Mradul Kumar Daga1, Naushad Ahmad Khan2, Harpreet Singh3, Ankit Chhoda4, Sahil Mattoo5, Basant Kumar Gupta6

1 Director Professor, Department of Medicine, Maulana Azad Medical College, New Delhi, India.
2 Research Associate, Department of Medicine, Maulana Azad Medical College, New Delhi, India.
3 Assistant Professor, Department of Medicine, Maulana Azad Medical College, New Delhi, India.
4 Senior Resident, Department of Medicine, Maulana Azad Medical College, New Delhi, India.
5 Resident, Department of Medicine, Maulana Azad Medical College, New Delhi, India.
6 Resident, Department of Medicine, Maulana Azad Medical College, New Delhi, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Mradul Kumar Daga, (Director Professor), 129, B.L.Taneja Block, Department of Medicine, Maulana Azad Medical College, New Delhi -110002, India.
E-mail: drmraduldaga@gmail.com
Abstract

Introduction

Sepsis is the leading cause of mortality in non-coronary Intensive Care Units (ICUs). Oxidative stress is one of the important features in pathogenesis of sepsis.

Aim

This study was undertaken to evaluate levels of oxidants and antioxidants in patients with sepsis admitted to ICU.

Study Design: This was a non-interventional clinical case-control study undertaken at a tertiary level teaching hospital in New Delhi, India.

Materials and Methods

Forty-six condivutive non-pediatric patients admitted to ICU with sepsis were included and subjected to detailed history, physical examination and investigations. Blood samples were drawn to evaluate oxidant Malondialdehyde (MDA) and antioxidant (alpha-tocopherol) levels. Acute Physiology and Chronic Health Evaluation II (APACHE II) and Organ Dysfunction and/or Infection (ODIN) scores were calculated and patients followed up for outcomes. Twenty age and sex matched healthy subjects served as controls.

Results

Mean levels of malondialdehyde were higher in patients than controls (17.2±3.8nm/ml versus 4.6±1.6nm/ml, p<0.001) while levels of alpha-tocopherol were lower (3.2±1.3μg/ml versus 9.9±2.0μg/ml, p<0.001). The mean APACHE II and ODIN scores were 18.1±9.3 and 1.7±1.3 respectively in patients. These scores were two to three fold higher in non survivor patients (n=22) in comparison with survivors (n=18) (p<0.001). There was no significant difference between the two groups in oxidants and antioxidants levels (p>0.05). However, a significant and positive correlation was observed between oxidant -antioxidant levels and APACHE II, ODIN and International Normalized Ratio (INR) scores in septic patients overall.

Conclusion

The oxidants in septic patients were significantly higher while antioxidants were significantly lower than healthy controls. There was also a significant correlation with APACHE II and ODIN scores. A large patient population based study may draw more specific conclusions.

Keywords

Introduction

The incidence of sepsis has increased considerably since the last few decades. Malnutrition, poverty, lack of access to vaccines and timely treatment, all contribute to death and in the developing world the mortality rate have been reported to be ranging from 60-80% due to sepsis [1]. Sepsis is defined as systemic response to infection [2]. It has been reported to be the commonest, resource consuming and causative factor for frequently fatal conditions, associated with many deaths in non-coronary Intensive Care Units (ICU) [3]. It is also said to reduce the long term quality of life of the survivors [4,5]. Patients with sepsis are exposed to severe oxidative stress, resulting from an oxidant antioxidant imbalance. Oxidative damage results due to an imbalance between oxidants and antioxidants and includes oxidative modification of cellular macromolecules, induction of cell death as well as structural tissue damage [6]. The use of antioxidant therapy has long been advocated for blunting the oxidative stress and thereby reducing the inflammatory response and its negative impact on the body [7,8]. The oxidant and antioxidant state in septic patients has been scarcely evaluated and only few studies have been done on septic patients correlating the severity of illness and patient outcome with oxidant and antioxidant levels [912]. It was thought that a well-structured study of patients of sepsis and their levels of oxidants and antioxidants would be of immense help in understanding the role of oxidative stress in sepsis. Many studies have reported a higher antioxidant state, determined by different compounds in non-surviving than in surviving septic patients [1012]. MDA is a low molecular weight aldehyde that results from free radical attacks on polyunsaturated fatty acids. Hence, MDA measurement can be considered as a valuable screening tool of indicator oxidative damage [13]. Recently, Lorente and colleagues have demonstrated increased levels of MDA in the serum of adults with severe sepsis. They reported that the non–survivors exhibited higher MDA levels than survivors suggesting that oxidative stress mediated by lipid peroxidation, contributes to sepsis pathophysiology [14]. Therefore, measurement of MDA levels is appropriate for the early estimation and quantification of oxidative damage. In healthy individuals, oxidant levels are stabilized by anti-oxidants. Alpha tocopherol – an endogenous lipid soluble chain breaking and the most active form of Vitamin E- is a powerful anti-oxidant and protects polyunsaturated fatty acids found in cell membrane phospholipids from the effects of free radicals by donating its hydrogen atom [15]. Vitamin E is shown to attenuate endotoxin- induced activation of alveolar macrophages [16] and is involved in septic shock in humans [17]. The present preliminary study was undertaken with the objective of measuring MDA and alpha tocopherol levels in patients with sepsis and to find out any correlation of these to disease severity and final outcome.

Materials and Methods

This was a non-interventional clinical case control study undertaken in the Departments of Internal Medicine and Biochemistry at Maulana Azad Medical College and associated Lok Nayak Hospital, a tertiary level teaching hospital in New Delhi, India. The study recruited patients from medical and surgical ICUs over a 3 month period. The criteria used for labeling a patient as having sepsis were those set by Bones et al., [18]. Sepsis = the systemic response to infection, manifested by two or more of the following conditions as a result of infection: (1) Temperature >38oC or <36oC; (2) Heart rate >90 beats per minute; (3) Respiratory rate >20 breaths per minute or PaCO2, <32mm Hg; and white blood cell count >12,000/cumm, <4,000/cumm, or >10% immature (band) forms. Exclusion criteria were: age <12 years, pregnancy, lactation, Human Immunodeficiency Virus (HIV), and white blood cell count <1,000 cells/μl, solid or haematological tumour, or immunosuppressive, steroid or radiation therapy.

Forty six consecutive non-pediatric patients (age more than 12 years) diagnosed with sepsis were included in the study. Ethical approval was obtained from the Institutional Ethics Committee of the hospital. The patients were subjected to a detailed medical history that included demographic data, presenting complaints, history of present illness and any past history of prolonged illness or hospitalization. A thorough physical examination was done and following clinical variables were recorded for each patient. Sex, age, cultures and routine investigations – haematological, biochemical and radiological diabetes mellitus, chronic renal failure, Chronic Obstructive Pulmonary Disease (COPD), site of infection, leukocytes, platelets, International Normalized Ratio (INR), Severity of illness assessed by Acute Physiology and Chronic Health Evaluation II (APACHE-II) score [19], and Organ Dysfunction and/or Infection (ODIN) [20] scores were calculated for each patient.

Twenty healthy age and sex matched controls with no evidence of sepsis or underlying infectious etiology were selected for the purpose of comparison from the outpatients coming to Department of Medicine. Blood samples were collected from patients within 24 hours of making a diagnosis of sepsis for estimating serum MDA and alpha tocopherol levels.

MDA Serum and Plasma Alpha-Tocopherol Level Analysis: MDA levels were measured by Thiobarbituric Acid Reactive Substance (TBARS) reaction using microplate spectrophotometer reader and following the method described by Kikugawa et al., [21]. The serum concentration of the MDA level was expressed in nmol/ml. Plasma alpha tocopherol was estimated by Hansen and Warwick’s method by plotting relative fluorometer units versus concentration of the tocopherol standards on a standard curve. The plasma concentration of alpha tocopherol was expressed as μg/ml [22]. To avoid the possible dispersion of serum MDA and alpha tocopherol level results, all the samples were processed at the same time.

Statistical Analysis

Continuous variables are reported as medians and interquartile ranges. Categorical variables are reported as frequencies and percentages. Comparisons between groups for categorical variables were carried out with chi-square test and Spearman’s Rank Correlation Coefficient was used to determine correlation between MDA and alpha tocopherol levels and correlation of these with APACHE II and ODIN scores. Comparisons between pairs of groups separately for survivors and non-survivors in Oxidant and Antioxidant levels were carried out with Student’s t-test for repeated measures. The difference of means was used to calculate significance of difference of various parameters between survivors and non survivors. A p-value of less than 0.05 was considered statistically significant. Statistical analyses were performed with SPSS 17.0 (SPSS Inc., Chicago, IL, USA).

Results

Twenty five of the total patients (n=46) were females and 21 were males. Mean age was 43.2 ± 17.2 years and ranged from 14 to 76 years. More than half the patients (n=30) fulfilled three of the four criteria of sepsis and the rest conformed to four (n=11) and two (n=5) criteria respectively. Tachycardia was seen in 44 patients, temperatures of more than 38°C in 37 and hypothermia in 2, tachypnea in 22 patients, 19 (41.3%) patients were on ventilators and neutrophilic leucocytosis observed in 18 with one patient demonstrating leucopenia. The most common site of infection precipitating sepsis was the respiratory tract (41.3%) followed by abdominal (30.4%) urinary (19.5%) and skin (8.6%). Fever (n=43) remained the most frequently encountered presenting symptom in these patients, although a wide spectrum of symptomatology was observed. Chronic Obstructive Pulmonary Disease (COPD) (n=9; 19.5%) Hypertension (n=9; 19.5%), diabetes (n=8; 17.3%) and chronic renal failure (n=5; 10.8%) were common associated chronic conditions. Sixteen (34.7%) patients’ demonstrated gram positive cultures, Gram negative organisms were isolated in 13 (28.2%) patients.

In terms of biochemical results the levels of MDA in patients (17.2± 3.8 nM/ml) were about four folds than in controls (4.6 ± 1.6 nM/ml) (p<0.001) while the alpha tocopherol levels were less than one third (3.2 ± 1.3 versus 9.9 ± 2.0 μg/ml, p<0.001) [Table/Fig-1,2]. APACHE II and ODIN scores were 18.1 ± 9.3 and 1.7 ± 1.3 respectively. The APACHE II and ODIN scores of patients who did not survive were much higher as compared to those who survived (p<0.001) [Table/Fig-3]. These two groups (of survivors and non-survivors) however, failed to demonstrate any significant differences in terms of oxidant and antioxidant levels [Table/Fig-3]. For the patient group as a whole, we observed a significant and positive correlation between oxidant-antioxidant levels with APACHE II, ODIN scores and INR [Table/Fig-4].

Clinical and demographic characteristics of the septic patients (n=46).

CharacteristicsValue
Gender
 MaleFemale21 (45.6%)25 (54.3%)
Age (Yrs.)43.2 ± 17.2 (14-76)
COPD09 (19.5 %)
Diabetes Mellitus08 (17.3%)
Chronic Renal Failure05 (10.8%)
Hypertension09 (19.5%)
Ventilator Support19 (41.3%)
Site of Infection
RespiratoryAbdominalUrinarySkinNeurological19 (41.3%)14 (30.4%)09 (19.5%)04 (8.6%)01 (2.1%)
Responsible Microorganisms
Gram Positive n (%)Gram NegativeUnknown16 (34.7%)13 (28.2%) 17 (36.9 %)
Creatinine (mg/dl)Bilirubin (mg/dl)1.52 (0.7 0-3.24)1.42 (0.62-3.14)
INR1.34 (0.99-2.4)
APACHE II Score18.3±9.3
ODIN Score1.7±1.3
Oxidant(Malondialdehyde- MDA (Median nmol/ml)17.2±3.8nmol/ml
Antioxidant(Alpha Tocopherol (μg/ml)3.2±1.3 μg/ml

COPD: Chronic Obstructive Pulmonary Disease; INR: International Normalized Ratio; APACHE II = Acute Physiology and Chronic Health Evaluation –II; ODIN Score: Organ Dysfunction and/or Infection Data are presented as number (Percentage) or interquartile range (Median).


Malondialdehyde and alpha tocopherol (oxidants/antioxidants) serum levels in septic patients and controls.

InvestigationsCases (n=46)Controls (n=20)p-value
OxidantMalondialdehyde (nmol/ml)17.2±3.84.6±1.6<0.001
AntioxidantAlpha Tocopherol (μg/ml)3.2±1.39.9±2.0<0.001

The table describes the biochemical values obtained in cases and controls, and calculated p-values for statistical significance of the difference in means.


Comparison of outcome with studied parameters.

ValueNon survivors(n = 22)Survivors(n = 24)Total(n = 46)p-Value
APACHE II*24.1 ± 5.912.0 ± 8.018.1 ± 9.3< 0.001
ODIN**2.6 ± 0.90.9 ± 1.01.7 ± 1.3< 0.001
Oxidant(Malondialdehyde)(nM/ml)17.0 ± 4.217.5 ± 4.017.2 ± 3.8> 0.05
Antioxidant(Alpha tocopherol)(μg/ml)2.9 ± 0.73.0 ± 1.53.2 ± 1.3> 0.05

The table describes the comparisons between different parameters for Survivors vs. Non- Survivors. The p value described refers to the statistical significance of difference of means between these two groups.

* APACHE II - Acute Physiology and Chronic Health Evaluation II

** ODIN - Organ Dysfunction and/or Infection


Correlation of oxidant -antioxidant levels with age, APACHE score II, ODIN score and INR.

ParametersMDA Serum Levels (Oxidant)Alpha Tocopherol Levels (Antioxidant)
Ager=0.16; p= 0.08r=0.29; p=0.21
*APACHE IIr=0.32; p=0.004r=0.42; p<0.001
**ODIN Scorer=0.38; p=0.002r=0.34; p<001
INRr=0.28; p<0.001r=0.32; p<0.001

* APACHE II - Acute Physiology and Chronic Health Evaluation II

** ODIN - Organ Dysfunction and/or Infection

INR- International Normalized Ratio

r=Spearman’s Rank Correlation Coefficient


Discussion

There is no published study about oxidative stress and oxidant/anti-oxidant system evaluation from septic patients over 12 years. of age in the existing literature in India. To our knowledge, our study is the first hospital based pilot study providing data on oxidative and anti oxidative state in septic patients. The relevant findings can be summarized as: First, oxidant-antioxidant imbalance was evident in patients with sepsis. Second, the MDA serum levels (oxidant) were significantly higher in septic patients than controls and alpha tocopherol levels (antioxidants) were significantly lower in septic patients than controls. Third, a significant correlation was observed between oxidant and antioxidant serum levels and several indicators of sepsis. Taken together the results from our study indicate alteration of the oxidative and anti-oxidative state may represent a potential therapeutic target in the pathophysiology of sepsis.

We found that septic patients had higher mean serum levels of MDA than healthy controls (17.2 ± 3.8 nM/ml vs. 4.6 ± 1.6 nm/ml) respectively reflecting a state of lipid hyperoxidation. Antioxidant levels were significantly less in patients than controls (3.2±1.3 vs. 9.9±2.0). Recently, Lorente and colleagues have demonstrated increased levels of MDA in the serum of adults with severe sepsis than healthy controls [14]. A study by Scott L and Clifford reported an increase in serum levels of the biomarker of oxidative stress-induced lipid peroxidation, in adults with severe sepsis, particularly in non survivors [23]. Their finding further reinforced the role of oxidative stress as a mechanism of organ dysfunction, and thus a potential therapeutic target - in sepsis. In an another study by Ameen et al., it was assumed that lipid peroxidation resulted in production of Reactive Oxygen Species (ROS) which played an important role in pathogenesis of multiple organ dysfunction and septic shock associated with neonatal sepsis. The MDA levels were extremely higher in both full term and preterm neonates with sepsis than that in their corresponding controls [24]. Our findings too are in agreement with the results of above mentioned studies [14,24] and other one small study done on septic patients [9].

Goode HF and colleagues [17] reported both an increased level of oxyradical stress, as monitored by Thiobarbituric Acid Reactive Species (TBARS) and urine nitrite excretion, as well as a significant decrease in the level of several key antioxidant systems (alpha tocopherol, retinol, beta-carotene and lycopene). Higher levels of lipid peroxidation products [9,17] and lower plasma selenium [17] and ascorbic acid levels [25] were associated with higher incidence of Ministry of Finance (MOF) and worse prognosis.

In terms of culture positivity we found that positive cultures were seen in 62.9% patients, similar to other workers. Gram negative organisms accounted for 16 (34.7%) and gram positive organisms were obtained in 13 (28.2%) of the isolates. This is similar to the results of cultures performed by Lorente and colleagues [14] and Sands et al., [26] where 24.1% and 40% isolates were found to be gram negative respectively. The reason for relatively high percentage of gram negative organism isolates in our study could be attributed to the difference in prevalent bacterial flora in our ICU.

We found a significant correlation between serum MDA levels, Alpha tocopherol and several indicators of severity in sepsis, including INR, APACHE II score and ODIN score in these septic patients. Previous studies have reported a positive correlation between MDA and severity in septic patients [9,12,14]. In the study by Goode HF et al., patients with three or more failing organs showed higher MDA levels than patients with fewer failing organs [17]. Andresen et al., reported a positive correlation between peak MDA and peak lactate levels. However, no correlation was observed at day 1 [27].

In our study we found, non-surviving septic patients had significantly higher APACHE II and ODIN scores than surviving septic patients (p<0.001). However, we could not find a significant difference in oxidant –antioxidant levels between survivors and non survivors (p=0.05). This may due to the fact that our sample size was too small to demonstrate that oxidant and antioxidant levels were independently associated with survival in our patients with sepsis. Based upon this it seems evident that in our study oxidative stress failed to predict the poor prognosis and mortality, contrary to some previous studies. Alonso de Vega et al., observed in their study that the non survivors had a more severe oxidative stress, higher APACHE III scores, and higher plasma concentrations of markers of leukocyte activation, in comparison with survivors [28]. Here, we will like to emphasize that, none of the clinical studies done on septic patient has been able to establish a causal Relationship between oxidative stress and mortality. In a study by Cowley et al., oxidative stress was present in survivors as well as non-survivors at time of diagnosis [12]; but antioxidant levels increased to normal or supernormal level in patients who eventually recovered. This indicates that oxidative stress is universal in all patients with sepsis and it is recovery from this stress which is affecting patient outcome. Our study also endorses same view that it is not static value of oxidative stress, but dynamics of balance between oxidant and antioxidant forces that affects the disease progression and prognosis. Nature of these factors which leads to recovery in some patients still remains to be elucidated.

Strengths and Limitations

The strength of our study lies in the fact that it was a case control study conducted in the ICU setting and patients were enrolled consecutively which removes selection bias. Certain limitations should be recognized such as the fact that the sample size of the study was not pre -determined and was relatively small. Secondly, we studied a narrow selection of oxidant –antioxidant compounds and included a portion of the full cohort. We did not consider other potentially broad relevant oxidants- antioxidants which may act as a biomarker. An ideal study would encompass measuring of a broader range of other compounds of oxidants and antioxidants involving all subjects in the cohort. However, our preliminary study lays the foundation for a more comprehensive examination of a broader range of oxidants-antioxidants modulators in septic patients.

Conclusion

With the information gathered from our study, it can be foreseen that oxidant/anti-oxidant level may play an important role in pathogenesis of sepsis. Our study shows significant difference of oxidant and antioxidant parameters in septic patients in comparison to the healthy controls. Therefore, the study points at the importance of oxidative stress as a prognostic factor for sepsis and probably alpha tocopherol and MDA as promising molecules that deserves the attention of future research. The values of APACHE II and ODIN scores, which were found to be two to three folds higher in non survivors than survivors, may act as better indicators for prognostication and prediction of outcome. Will this translate into therapy for sepsis rather than only prognostic indicator? Further studies should also try to establish the possible benefits of combination of oxidants-antioxidants supplementation in septic patients. A study involving a large number of patients could perhaps lead to a better insight into the role of oxidative stress in sepsis.

COPD: Chronic Obstructive Pulmonary Disease; INR: International Normalized Ratio; APACHE II = Acute Physiology and Chronic Health Evaluation –II; ODIN Score: Organ Dysfunction and/or Infection Data are presented as number (Percentage) or interquartile range (Median).The table describes the biochemical values obtained in cases and controls, and calculated p-values for statistical significance of the difference in means.The table describes the comparisons between different parameters for Survivors vs. Non- Survivors. The p value described refers to the statistical significance of difference of means between these two groups.* APACHE II - Acute Physiology and Chronic Health Evaluation II** ODIN - Organ Dysfunction and/or Infection* APACHE II - Acute Physiology and Chronic Health Evaluation II** ODIN - Organ Dysfunction and/or InfectionINR- International Normalized Ratior=Spearman’s Rank Correlation Coefficient

References

[1]Jay P, Metabolic theory of septic shock World J Crit Care Med 2014 3(2):45-54.  [Google Scholar]

[2]Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR, Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 2001 29:1303-10.  [Google Scholar]

[3]Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Sepsis in European intensive care units: results of the SOAP study Crit Care Med 2006 34:344-53.  [Google Scholar]

[4]Perl TM, Dvorak L, Hwang T, Wenzel RP, Long-term survival and function after suspected gram-negative sepsis JAMA 1995 274:338-45.  [Google Scholar]

[5]Heyland DK, Hopman W, Coo H, Tranmer J, McColl MA, Long-term health-related quality of life in survivors of sepsis: Short Form-36: a valid and reliable measure of health-related quality of life Crit Care Med 2000 28(11):3599-605.  [Google Scholar]

[6]Salvemini D, Cuzzocrea S, Oxidative stress in septic shock and DIC Free Radic Biol Med 2002 33(9):1173-85.  [Google Scholar]

[7]Paterson RL, Galley HF, Webster NR, The effect of N-acety on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis Crit Care Med 2003 31:2574-78.  [Google Scholar]

[8]Basu S, Eriksson M, Retinol palmitate counteracts oxidative injury during experimental septic shock Ann Acad Med Singapore 2001 30(3):265-69.  [Google Scholar]

[9]Ogilvie AC, Groeneveld AB, Straub JP, Thijs LG, Plasma lipid peroxides and antioxidants in human septic shock Intensive Care Med 1991 17:40-44.  [Google Scholar]

[10]Chuang CC, Shiesh SC, Chi CH, Tu YF, Hor LI, Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis Crit Care 2006 10:R36  [Google Scholar]

[11]Guerreiro MO, Petronilho F, Andrades M, Constantino L, Mina FG, Moreira JC, Plasma superoxide dismutase activity and mortality in septic patients [corrected] J Trauma 2010 69:E102-06.  [Google Scholar]

[12]Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors Crit Care Med 1996 24:1179-83.  [Google Scholar]

[13]Mishra V, Baines M, Wenstone R, Shenkin A, Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients Ann Clin Biochem 2005 42:269-76.  [Google Scholar]

[14]Lorente L, Martín MM, González PA, Rodriguez AD, Labarta L, Díaz C, Sustained high serum malondialdehyde levels are associated with severity and mortality in septic patients Critical Care 2013 17:R290  [Google Scholar]

[15]Regina BF, Maret GT, Vitamin E: function and metabolism The Faseb J 1999 13:1145-55.  [Google Scholar]

[16]Mendez C, Garcia I, Maier RV, Antioxidant’s attenuate endotoxin-induced activation of alveolor macrophages Surgery 1995 118:412-20.  [Google Scholar]

[17]Lorente L, Martín MM, González PA, Rodriguez AD, Labarta L, Díaz C, Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction Crit CareMed 1995 23:646-51.  [Google Scholar]

[18]Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 1992 101(6):1644-55.  [Google Scholar]

[19]Knaus WA, Draper EA, Wagner DP, Zimmerman JE, APACHE II: a severity of disease classification system Crit Care Med 1985 13(10):818-29.  [Google Scholar]

[20]Fagon JY, Chastre J, Novara A, Medioni P, Gilbert C, Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model Intensive Care Med 1993 19(3):137-44.  [Google Scholar]

[21]Kikugawa K, Kojima T, Yamaki S, Kosugi H, Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylediaminotetraacetic acid Anal Biochem 1992 202:249-55.  [Google Scholar]

[22]Hansen LG, Warwick WJ, A fluorometric micro method for serum tocopherol Tech Bull Regist Med Technol 1966 36(6):131-36.  [Google Scholar]

[23]Scott LW, Clifford SD, Elevated malondialdehyde levels in sepsis - something to ‘stress’ about? Critical Care 2014 18:125  [Google Scholar]

[24]Ameen T, Moayad NM, Measurments of malondialdehyde levels (MDA) as a marker of lipidperoxidation in neonatal sepsis Thi-Qar Medical Journal. TQMJ 2011 5(2):9-17.  [Google Scholar]

[25]Borrelli E, Roux-Lombard P, Grau GE, Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk Crit Care Med 1996 24:392-97.  [Google Scholar]

[26]Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, Academic medical center consortium sepsis project working groupepidemio-logy of sepsis syndrome in 8 academic medical centers JAMA 1997 278(3):234-40.  [Google Scholar]

[27]Andresen M, Regueira T, Bruhn A, Perez D, Strobel P, Dougnac A, Lipoperoxidation and protein oxidative damage exhibit different kinetics during septic shock Mediators of Inflammation 2008 2008:1686528 pages, 2008  [Google Scholar]

[28]Alonso de, Vega JM, Diaz J, Serrano E, Carbonell LF, Oxidative stress in critically ill patients with systemic inflammatory response syndrome Crit Care Med 2002 30:1782-86.  [Google Scholar]